Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 02, 2018
Experic marked its official launch by announcing it has leased a 45,500 square foot, state-of-the-art Class A research, manufacturing and packaging facility located in Cranbury, New Jersey.
read more
Tuesday, September 10, 2019
Experic has announced Denise Sabaday has been appointed vice president of business development.
read more
Monday, September 16, 2019
Experic has announced Denise Sabaday as vice president of business development.
read more
Experic has announced the hire of Sherry Ann D’Iorio as executive director of business development.
read more
Experic announced a strategic collaboration with Flurry Powders to bring together complementary expertise to accelerate development of next generation therapies requiring advanced particle engineering.
read more
Experic announced the addition of spray drying capabilities to support the formulation and development of biopharmaceuticals. The new spray drying services will be available from its facility located in Cranbury, New Jersey.
read more
Wednesday, April 22, 2020
Keystone Folding Box has incorporated new die cutting and gluing equipment into its production facility.
read more
Exothera has launched its nucleic acids service offering, powered by their continuous-batch RNA production platform, Ntensify™. Developed by Exothera sister company Quantoom Biosciences, the Ntensify™ platform fast-tracks the production of higher ...
read more
Wednesday, March 23, 2022
Exothera S.A. received Good Manufacturing Practices (GMP) certification from the Federal Agency for Medicines and Health Products (FAMHP) for its facilities in Jumet, Belgium. This accreditation follows a series of successful inspections ensuring ...
read more
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
read more
Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.
read more
Exothera S.A. has developed and is continuing improving the exoREADY platform for accelerated viral vector manufacture. This fully integrated platform will ensure faster, more cost-effective production of viral vector-based therapeutics (for gene ...
read more
Exothera has acquired the NevoLine Upstream manufacturing platform, the latest equipment of Univercells Technologies.
read more
Friday, November 06, 2015
Exostar, a provider of secure cloud-based solutions that improve identity access management, is now certified by SAFE-BioPharma Association to issue SHA-2 compliant public key infrastructure (PKI) digital certificates for use in the life sciences and...
read more
Tuesday, January 21, 2020
Exosomics has implemented NanoFCM’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide.
read more